Key facts
- This page summarizes Ian Morgan Charles's Form 4 filing for Glimpse Group, Inc. (VRAR).
- 3 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 05 Mar 2024, 10:12.
Ian Morgan Charles - 29 Feb 2024 Form 4 Insider Report for Glimpse Group, Inc. (VRAR)
- Reporting relationship
- Director
- Issuer ticker
- VRAR
- Reported as of
- 29 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Mar 2024, 10:12:59 UTC
- Prior SEC filing
- 01 Jun 2023
- Next SEC filing
- 27 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Ian Charles
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ian Morgan Charles filed Form 4 for Glimpse Group, Inc. (VRAR) on 05 Mar 2024.
Change
- Previous filing in this sequence was filed on 01 Jun 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VRAR
transaction
Derivative
Stock Option (Right to Purchase)
Disposed to Issuer
- Transaction value
- $0
- Shares
- -30,560
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 29 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 30,560
- Exercise price
- Footnotes
- F1
VRAR
transaction
Derivative
Stock Option (Right to Purchase)
Award
- Transaction value
- $0
- Shares
- +20,475
- Change %
- +85%
- Price
- $0.000000
- Shares after
- 44,475
- Date
- 01 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,475
- Exercise price
- $2.50
- Footnotes
- F2
VRAR
transaction
Derivative
Stock Option (Right to Purchase)
Award
- Transaction value
- $0
- Shares
- +24,000
- Change %
- +117%
- Price
- $0.000000
- Shares after
- 44,475
- Date
- 01 Mar 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 24,000
- Exercise price
- $2.50
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Represents the forfeiture, by Mr. Charles, of fully vested options to purchase an aggregate of 30,560 shares of the issuer's common stock granted under the issuer's 2016 equity incentive plan, as amended (the "2016 Plan"), consisting of (i) options to purchase 10,560 shares of the issuer's common stock granted to Mr. Charles on January 13, 2022 with an exercise price of $10.09 per share, and (ii) options to purchase 20,000 shares of the issuer's common stock granted to Mr. Charles on February 27, 2023 with an exercise price of $5.00 per share. The foregoing options were to expire 10 years from their respective grant dates.
Footnote F2
Mr. Charles was granted options to purchase 20,475 shares of the issuer's common stock under the 2016 Plan on March 1, 2023, which options became exercisable upon grant with an exercise price of $2.50 per share. These options are set to expire seven years from grant date.
Footnote F3
Represents options to purchase 24,000 shares of the issuer's common stock granted to Mr. Charles on March 1, 2024, as director compensation for calendar year 2024. The options vest monthly in arrears, retroactive to January 1, 2024 with an exercise price of $2.50 per share. These options are set to expire 10 years from grant date.